Ashley Hall
Net worth: 2 M $ as of 2026-05-30
Net worth: 2 M $ as of 2026-05-30
Ms. Ashley F.
Hall is a Chief Development Officer at Structure Therapeutics, Inc. Ms. Hall was previously employed as a Chief Development Officer by Reneo Pharmaceuticals, Inc., a Senior VP-Global Regulatory Affairs & Policy by Esperion Therapeutics, Inc., a Vice President-Regulatory Affairs by Amgen Rockville, Inc., a Director-World Wide Regulatory Affairs by MedImmune LLC, a Vice President-Regulatory Affairs by CancerVax Corp., a Vice President-Regulatory Affairs by Micromet, Inc., and a Vice President-Regulatory & Clinical Affairs by Revogenex Ltd. She received her undergraduate degree from the University of California San Diego and a graduate degree from the University of San Diego School of Law.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-18 | 155,187 ( 0.11% ) | 2 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Corporate Officer/Principal | 2024-09-17 |
| Companies | Position | End |
|---|---|---|
| ONKURE THERAPEUTICS, INC. | Corporate Officer/Principal | 2024-09-12 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | General Counsel | 2012-04-30 |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | General Counsel | 2009-07-31 |
Micromet Inc.
Micromet Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases | General Counsel | - |
CancerVax Corp.
CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | General Counsel | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
CancerVax Corp.
CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | Commercial Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Health Technology |
Revogenex Ltd.
Revogenex Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of San Diego School of Law
University of San Diego School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases | Health Technology |
Structure Therapeutics, Inc.
Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Micromet Inc.
Micromet Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions